Act now to fight for the health of transplant patients!
Tell your Members of Congress: STOP private contractors from rolling back and restricting Medicare coverage for crucial transplant rejection blood tests.
In March, a private contractor called “MolDX” rolled back Medicare coverage for transplant recipients to receive non-invasive blood tests to discover early signs of rejection. Among other restrictions, Medicare will now only cover the blood test for the surveillance of organ health if the doctor would have otherwise performed an invasive biopsy. If we don’t stop Medicare, patients may have to depend on invasive biopsies or worse, wait until their body shows signs of rejection.
We need your help to urge your Members of Congress to ask the Biden Administration to stop Medicare from harming patients and to intervene now to restore coverage for crucial transplant rejection blood tests.